Short Sellers Swarming Avanir s Stock, Driving Down Share Price (San Diego Business Journal)
Clarification: In a story appearing in the Oct. 2 print edition, the Business Journal said biotech analyst John McCamant said he does not think Avanir Pharmaceuticals drug Neurodex would receive approval from the federal Food and Drug Administration.

Arixtra(R) Receives Priority Review By The FDA In Acute Coronary Syndromes (ACS) (Medical News Today)
Australian drug development company Alchemia Limited (ASX: ACL) received further positive news for its Synthetic Heparin with the priority review for GlaxoSmithKline's (GSK) supplemental new drug application (sNDA) for Arixtra(R) in treating acute coronary syndromes (ACS) by the US Food and Drug Administration. [click link for full article]

Gen-Probe Receives FDA Approval for APTIMA(R) HIV-1 RNA Qualitative Assay for Clinical Diagnostic Use (RedNova)
SAN DIEGO, Oct. 5 /PRNewswire-FirstCall/ -- Gen-Probe announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for the APTIMA(R) HIV-1 RNA qualitative assay.